150 related articles for article (PubMed ID: 27788759)
1. Matched unrelated donor transplants-State of the art in the 21st century.
Altaf SY; Apperley JF; Olavarria E
Semin Hematol; 2016 Oct; 53(4):221-229. PubMed ID: 27788759
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation from unrelated donors in acute leukaemia.
Lozano Cerrada S; Altaf SY; Olavarria E
Curr Opin Oncol; 2018 Nov; 30(6):418-424. PubMed ID: 30222641
[TBL] [Abstract][Full Text] [Related]
3. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
[TBL] [Abstract][Full Text] [Related]
5. Unrelated donor haematopoietic stem cell transplantation for adult patients with haematological malignancies.
Huang H; Lai XY
Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):22-6. PubMed ID: 19494392
[TBL] [Abstract][Full Text] [Related]
6. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
7. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings.
Michallet M; Sobh M; Serrier C; Morisset S; Labussière H; Ducastelle S; Barraco F; Gilis L; Thomas X; Nicolini FE
Leuk Lymphoma; 2015 Apr; 56(4):999-1003. PubMed ID: 25029640
[TBL] [Abstract][Full Text] [Related]
9. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
Kindwall-Keller TL; Ballen KK
Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
[TBL] [Abstract][Full Text] [Related]
10. Unrelated donor bone marrow transplantation for hematological malignancies-current status.
Davies SM; Wagner JE; Weisdorf DJ; Shu XO; Blazar BR; Enright H; McGlave PB; Ramsay NK
Leuk Lymphoma; 1996 Oct; 23(3-4):221-6. PubMed ID: 9031102
[TBL] [Abstract][Full Text] [Related]
11. Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.
Shaw BE; Mayor NP; Szydlo RM; Bultitude WP; Anthias C; Kirkland K; Perry J; Clark A; Mackinnon S; Marks DI; Pagliuca A; Potter MN; Russell NH; Thomson K; Madrigal JA; Marsh SGE
Bone Marrow Transplant; 2017 May; 52(5):717-725. PubMed ID: 28092349
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
[No Abstract] [Full Text] [Related]
13. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors.
Hows JM; Passweg JR; Tichelli A; Locasciulli A; Szydlo R; Bacigalupo A; Jacobson N; Ljungman P; Cornish J; Nunn A; Bradley B; Socié G; ;
Bone Marrow Transplant; 2006 Dec; 38(12):799-805. PubMed ID: 17075568
[TBL] [Abstract][Full Text] [Related]
14. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
15. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation.
Rockstroh A; Al-Ali HK; Lange T; Pönisch W; Krahl R; Cross M; Behre G; Niederwieser D; Pfrepper C
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2193-203. PubMed ID: 26129640
[TBL] [Abstract][Full Text] [Related]
16. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
[TBL] [Abstract][Full Text] [Related]
17. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.
Bashey A; Zhang X; Sizemore CA; Manion K; Brown S; Holland HK; Morris LE; Solomon SR
J Clin Oncol; 2013 Apr; 31(10):1310-6. PubMed ID: 23423745
[TBL] [Abstract][Full Text] [Related]
18. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
[TBL] [Abstract][Full Text] [Related]
19. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.
Verneris MR; Lee SJ; Ahn KW; Wang HL; Battiwalla M; Inamoto Y; Fernandez-Vina MA; Gajewski J; Pidala J; Munker R; Aljurf M; Saber W; Spellman S; Koreth J
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1783-9. PubMed ID: 26055300
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]